APHA
Back to Annual Meeting Page
 
American Public Health Association
133rd Annual Meeting & Exposition
December 10-14, 2005
Philadelphia, PA
APHA 2005
 
3332.0: Monday, December 12, 2005 - Board 1

Abstract #101608

Evaluation of a unique stroke and heart attack prevention program

D. Orenstein, PhD, Cardiovascular Health Branch, Division of Adult and Community Health, Centers for Disease Control and Prevention, 4770 Buford Hwy. NE MS K-47, Atlanta, GA 30341, 770 488 8003, dro1@cdc.gov, J. Nell Brownstein, PhD, Cardiovascular Health Branch, NCCDPHP, CDC, 4770 Bufford Highway NE, MS K47, Atlanta, GA 30341-3717, Roberta Constantine, PhD, Research Triangle Institute, 3040 Cornwallis Rd., Research Triangle Park, NC 27709, and Pat Jones, RN, CDE, Chronic Diseae Prevention and Health Promotion Branch, Georgia Division of Public Health, 2 Peachtree stree, 16.463, Atlanta, GA 30303.

Evaluation of a unique stroke and heart attack prevention program

Learning Objectives: 1. Identify three critical factors that contribute to successful blood pressure control 2. Describe how these factors were implemented in the SHAPP clinics. 3. Articulate two policy implications resulting from this project. 4. Describe two practical applications for other community health programs

Description: The Stroke and Heart Attack Prevention Program (SHAPP), funded by the Georgia Legislature since 1974, provides services for blood pressure screening, diagnosis, and treatment. Implemented through the Georgia Department of Human Resources, medically indigent adults are eligible for hypertension medications at low or no cost. Of the more than 15,000 patients served by SHAPP, the largest segments include persons 30 to 59 years of age and African Americans. This research provided in-depth case studies of two of the 19 districts with control rates much higher than the national average. The objective was to identify critical components contributing to successful blood pressure control and examine how they were implemented. This mixed method evaluation included: 1) in-depth interviews with administrators and clinic staff, 2) focus groups with patients, 3) medical record abstraction, and 4) cost analysis to estimate the per-patient cost. We will provide an overview of methodologies and data sources used to evaluate SHAPP and present practical applications of our findings as well as policy implications and cost analysis.

Learning Objectives: Learning Objectives

Presenting author's disclosure statement:

I wish to disclose that I have NO financial interests or other relationship with the manufactures of commercial products, suppliers of commercial services or commercial supporters.

Expanding Our Concept of Health Promotion, Disease Prevention

The 133rd Annual Meeting & Exposition (December 10-14, 2005) of APHA